IMM 1.45% 34.0¢ immutep limited

Ann: Immutep AIPAC Ph2b Clinical Results & Update Webcast Slides, page-26

  1. 1,099 Posts.
    lightbulb Created with Sketch. 199
    "they did not expect the shareholder response"
    Then they are not as smart as we are led to believe. This is what biotechs do when people are led along and then have no delivery, or sub what was promised, delivery. Let it be a lesson, PRR/IMM has history.
    Simple- underpromise, overdeliver.And the opposite to this debacle will occur.
    And I thought I was smart buying more at 25c a week or so ago, right at the bottom.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.